TRexBio Secures $84M to Advance Immunology Pipeline
13 Nov 2024 //
BUSINESSWIRE
TRexBio Announces Lilly Has Initiated Phase 1 Study for Autoimmune Diseases
26 Jun 2024 //
BUSINESSWIRE
TRexBio Announces a First Option Was Exercised by Partner
03 Jan 2024 //
BUSINESSWIRE
TRexBio Announces Development Candidate, TRB-061
14 Nov 2023 //
BUSINESSWIRE
Lilly pays $55M to ride TRex into regulatory T-cell space
09 Jan 2023 //
FIERCE BIOTECH